Short-term treatment of iron deficiency anemia after cardiac surgery

[1]  P. Vandervoort,et al.  The effect of intravenous ferric carboxymaltose on cardiac reverse remodelling following cardiac resynchronization therapy—the IRON-CRT trial , 2021, European heart journal.

[2]  T. Kempf.  Iron supplementation in acute heart failure: energize your life. , 2021, European heart journal.

[3]  L. Pierelli,et al.  Preoperative Sucrosomial Iron Supplementation Increases Haemoglobin and Reduces Transfusion Requirements in Elective Heart Surgery Patients: A Prospective Randomized Study. , 2021, Surgical technology international.

[4]  J. Cleland,et al.  Natural history and prognostic significance of iron deficiency and anaemia in ambulatory patients with chronic heart failure , 2021, European journal of heart failure.

[5]  D. Okonko,et al.  Oral sucrosomial iron in heart failure with a reduced ejection fraction , 2021, European journal of heart failure.

[6]  M. Petrie,et al.  Intravenous iron for heart failure with evidence of iron deficiency: a meta-analysis of randomised trials , 2021, Clinical Research in Cardiology.

[7]  M. Bellini,et al.  Oral Sucrosomial Iron Is as Effective as Intravenous Ferric Carboxy-Maltose in Treating Anemia in Patients with Ulcerative Colitis , 2021, Nutrients.

[8]  D. Farmakis,et al.  Oral sucrosomial iron improves exercise capacity and quality of life in heart failure with reduced ejection fraction and iron deficiency: a non‐randomized, open‐label, proof‐of‐concept study , 2021, European journal of heart failure.

[9]  M. Napolitano,et al.  Oral high-dose sucrosomial iron vs intravenous iron in sideropenic anemia patients intolerant/refractory to iron sulfate: a multicentric randomized study , 2020, Annals of Hematology.

[10]  P. Ponikowski,et al.  Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial , 2020, The Lancet.

[11]  Ethan Y. Brovman,et al.  The Impact of Preoperative Intravenous Iron Therapy on Perioperative Outcomes in Cardiac Surgery: A Systematic Review , 2020, Journal of hematology.

[12]  L. Mbuagbaw,et al.  Iron deficiency following bariatric surgery: a retrospective cohort study. , 2020, Blood advances.

[13]  R. Schnabel,et al.  Iron Metabolism Contributes to Prognosis in Coronary Artery Disease: Prognostic Value of the Soluble Transferrin Receptor Within the AtheroGene Study , 2020, Journal of the American Heart Association.

[14]  S. Blankenberg,et al.  Iron deficiency is a common disorder in general population and independently predicts all-cause mortality: results from the Gutenberg Health Study , 2020, Clinical Research in Cardiology.

[15]  F. Giallauria,et al.  Effect of intravenous iron replacement therapy on exercise capacity in iron deficient anemic patients after cardiac surgery. , 2020, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[16]  M. Tiwari,et al.  Iron deficiency in non-anemic chronic obstructive pulmonary disease in a predominantly male population: an ignored entity. , 2020, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[17]  M. Wolf,et al.  Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials. , 2020, JAMA.

[18]  Jinping Liu,et al.  Incidence, Risk Factors, and Outcomes of Hyperferritinemia after Pediatric Cardiac Surgery with Cardiopulmonary Bypass: A Retrospective Study , 2020 .

[19]  D. Girelli,et al.  Intravenous Iron Promotes Low-Grade Inflammation in Anemic Patients By Triggering Macrophage Activation , 2019, Blood.

[20]  B. Seifert,et al.  Effect of ultra-short-term treatment of patients with iron deficiency or anaemia undergoing cardiac surgery: a prospective randomised trial , 2019, The Lancet.

[21]  G. Wells,et al.  The Effect of Preoperative Anemia on Patients Undergoing Cardiac Surgery: A Propensity-Matched Analysis. , 2019, Seminars in thoracic and cardiovascular surgery.

[22]  G. Kemp,et al.  Effect of Iron Isomaltoside on Skeletal Muscle Energetics in Patients With Chronic Heart Failure and Iron Deficiency. , 2019, Circulation.

[23]  J. McMurray,et al.  Intravenous Iron in Patients Undergoing Maintenance Hemodialysis. , 2019, The New England journal of medicine.

[24]  J. McMurray,et al.  Intravenous Iron in Patients Undergoing Maintenance Hemodialysis , 2019, The New England journal of medicine.

[25]  P. Ponikowski,et al.  Iron Deficiency in Heart Failure: An Overview. , 2019, JACC. Heart failure.

[26]  R. Burwick,et al.  Treatment of Iron Deficiency Anemia in Pregnancy with Intravenous versus Oral Iron: Systematic Review and Meta-Analysis , 2018, American Journal of Perinatology.

[27]  B. Seifert,et al.  Iron deficiency is associated with higher mortality in patients undergoing cardiac surgery: a prospective study. , 2019, British journal of anaesthesia.

[28]  Y. Zambito,et al.  Ex Vivo and in Vivo Study of Sucrosomial® Iron Intestinal Absorption and Bioavailability , 2018, International journal of molecular sciences.

[29]  H. Kehlet,et al.  An international consensus statement on the management of postoperative anaemia after major surgical procedures , 2018, Anaesthesia.

[30]  R. Schnabel,et al.  Adverse Outcome Prediction of Iron Deficiency in Patients with Acute Coronary Syndrome , 2018, Biomolecules.

[31]  I. Anand,et al.  Anemia and Iron Deficiency in Heart Failure: Current Concepts and Emerging Therapies , 2018, Circulation.

[32]  N. Marx,et al.  High-Dose Ferric Carboxymaltose in Patients With HFrEF Induces Significant Hypophosphatemia. , 2018, Journal of the American College of Cardiology.

[33]  F. Verbrugge,et al.  Impact of iron deficiency on exercise capacity and outcome in heart failure with reduced, mid-range and preserved ejection fraction , 2018, Acta cardiologica.

[34]  B. Giepmans,et al.  Iron deficiency impairs contractility of human cardiomyocytes through decreased mitochondrial function , 2018, European journal of heart failure.

[35]  P. Meybohm,et al.  Post-Operative Iron Carboxymaltose May Have an Effect on Haemoglobin Levels in Cardiothoracic Surgical Patients on the ICU - an Observational Pilot Study about Anaemia Treatment with Intravenous Iron , 2018, Transfusion Medicine and Hemotherapy.

[36]  S. Fogli,et al.  Sucrosomial® iron absorption studied by in vitro and ex‐vivo models , 2018, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[37]  P. Ponikowski,et al.  Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron‐deficient heart failure patients: an individual patient data meta‐analysis , 2018, European journal of heart failure.

[38]  P. Ponikowski,et al.  Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency , 2017, Circulation.

[39]  K. Anstrom,et al.  Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency: The IRONOUT HF Randomized Clinical Trial , 2017, JAMA.

[40]  M. Pavesi,et al.  Patterns and determinants of functional and absolute iron deficiency in patients undergoing cardiac rehabilitation following heart surgery , 2017, European journal of preventive cardiology.

[41]  A. Rigby,et al.  Prevalence and Outcomes of Anemia and Hematinic Deficiencies in Patients With Chronic Heart Failure. , 2016, JAMA cardiology.

[42]  N. Westerhof,et al.  Intravenous Iron Therapy in Patients with Idiopathic Pulmonary Arterial Hypertension and Iron Deficiency , 2015, Pulmonary circulation.

[43]  P. Ponikowski,et al.  Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency† , 2014, European heart journal.

[44]  T. Richards,et al.  A prospective observational cohort study to identify the causes of anaemia and association with outcome in cardiac surgical patients , 2014, Heart.

[45]  A. Cohen-Solal,et al.  High prevalence of iron deficiency in patients with acute decompensated heart failure , 2014, European journal of heart failure.

[46]  M. Caputo,et al.  Preoperative anemia increases mortality and postoperative morbidity after cardiac surgery , 2010, Journal of Cardiothoracic Surgery.

[47]  Douglas B Kell,et al.  Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells. , 2014, Metallomics : integrated biometal science.

[48]  A. Jiménez-Sosa,et al.  The effect of intravenous and oral iron administration on perioperative anaemia and transfusion requirements in patients undergoing elective cardiac surgery: a randomized clinical trial. , 2012, Interactive cardiovascular and thoracic surgery.

[49]  G. Pelissero,et al.  Impact of preoperative anemia on outcome in adult cardiac surgery: a propensity-matched analysis. , 2012, The Annals of thoracic surgery.

[50]  P. Ponikowski,et al.  Ferric carboxymaltose in patients with heart failure and iron deficiency. , 2009, The New England journal of medicine.

[51]  P. Ponikowski,et al.  Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial. , 2007, Journal of the American College of Cardiology.

[52]  Chris A Rogers,et al.  Increased Mortality, Postoperative Morbidity, and Cost After Red Blood Cell Transfusion in Patients Having Cardiac Surgery , 2007, Circulation.

[53]  P. Duarte,et al.  Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. , 2007, Journal of the American College of Cardiology.

[54]  D. Jacobs,et al.  Comparison of the serum ferritin and percentage of transferrin saturation as exposure markers of iron-driven oxidative stress-related disease outcomes. , 2006, American heart journal.

[55]  Jerry Kaplan,et al.  Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization , 2004, Science.

[56]  ATS Statement , 2002 .

[57]  ATS statement: guidelines for the six-minute walk test. , 2002, American journal of respiratory and critical care medicine.

[58]  R. Stoltzfus,et al.  Defining iron-deficiency anemia in public health terms: a time for reflection. , 2001, The Journal of nutrition.

[59]  N. Andrews,et al.  Disorders of iron metabolism. , 1999, The New England journal of medicine.